JP2022513331A5 - - Google Patents

Info

Publication number
JP2022513331A5
JP2022513331A5 JP2021543565A JP2021543565A JP2022513331A5 JP 2022513331 A5 JP2022513331 A5 JP 2022513331A5 JP 2021543565 A JP2021543565 A JP 2021543565A JP 2021543565 A JP2021543565 A JP 2021543565A JP 2022513331 A5 JP2022513331 A5 JP 2022513331A5
Authority
JP
Japan
Prior art keywords
seq
chain variable
antibody according
variable domain
domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021543565A
Other languages
English (en)
Japanese (ja)
Other versions
JP7610515B2 (ja
JP2022513331A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/076772 external-priority patent/WO2020070225A1/en
Publication of JP2022513331A publication Critical patent/JP2022513331A/ja
Publication of JP2022513331A5 publication Critical patent/JP2022513331A5/ja
Application granted granted Critical
Publication of JP7610515B2 publication Critical patent/JP7610515B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021543565A 2018-10-04 2019-10-02 ヒト化抗N短縮型アミロイドβモノクローナル抗体 Active JP7610515B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1816210.7 2018-10-04
GB201816210 2018-10-04
PCT/EP2019/076772 WO2020070225A1 (en) 2018-10-04 2019-10-02 Humanised anti-n-truncated amyloid beta monoclonal antibody

Publications (3)

Publication Number Publication Date
JP2022513331A JP2022513331A (ja) 2022-02-07
JP2022513331A5 true JP2022513331A5 (https=) 2022-10-06
JP7610515B2 JP7610515B2 (ja) 2025-01-08

Family

ID=68136417

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021543565A Active JP7610515B2 (ja) 2018-10-04 2019-10-02 ヒト化抗N短縮型アミロイドβモノクローナル抗体

Country Status (13)

Country Link
US (1) US12297261B2 (https=)
EP (1) EP3861023A1 (https=)
JP (1) JP7610515B2 (https=)
KR (1) KR102862077B1 (https=)
CN (1) CN113056480B (https=)
AU (1) AU2019354714A1 (https=)
BR (1) BR112021006153A2 (https=)
CA (1) CA3114669A1 (https=)
EA (1) EA202190954A1 (https=)
IL (1) IL281979B2 (https=)
MX (1) MX2021003867A (https=)
SG (1) SG11202102765RA (https=)
WO (1) WO2020070225A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111201030B (zh) 2017-07-25 2024-11-01 真和制药有限公司 通过阻断tim-3和其配体的相互作用治疗癌症
WO2020160156A2 (en) 2019-01-30 2020-08-06 Immutics, Inc. Anti-gal3 antibodies and uses thereof
EP4118111A1 (en) 2020-03-10 2023-01-18 LifeArc Cyclic peptides
EP4157338A4 (en) 2020-05-26 2024-11-13 TrueBinding, Inc. METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING
PE20252307A1 (es) 2022-12-22 2025-09-22 Bioarctic Ab Anticuerpo que se une a abetape3
WO2025262228A1 (en) 2024-06-20 2025-12-26 Bioarctic Ab Bispecific binding molecule

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US474900A (en) 1892-05-17 William byrnes
US4704362A (en) 1977-11-08 1987-11-03 Genentech, Inc. Recombinant cloning vehicle microbial polypeptide expression
EP0832981A1 (en) 1987-02-17 1998-04-01 Pharming B.V. DNA sequences to target proteins to the mammary gland for efficient secretion
US5633076A (en) 1989-12-01 1997-05-27 Pharming Bv Method of producing a transgenic bovine or transgenic bovine embryo
US5827690A (en) 1993-12-20 1998-10-27 Genzyme Transgenics Corporatiion Transgenic production of antibodies in milk
WO2008081008A1 (en) * 2007-01-05 2008-07-10 University Of Zurich Method of providing disease-specific binding molecules and targets
MY155144A (en) 2007-10-29 2015-09-15 Inst Nat Sante Rech Med NEW ANTIBODIES SPECIFIC OF THE ß-AMYLOID PEPTIDES AND THEIR USES AS DIAGNOSTIC AGENTS OR DRUGS
WO2011151076A2 (en) * 2010-06-04 2011-12-08 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin MONOCLONAL ANTIBODIES TARGETING Αβ OLIGOMERS
EP2847217B1 (en) 2012-05-10 2017-10-11 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin CONFORMATIONAL-SPECIFIC ANTIBODIES AGAINST OLIGOMERS of Amyloid beta
WO2015173133A1 (en) 2014-05-12 2015-11-19 Chiesi Farmaceutici S.P.A. Formulations and methods of treating alzheimer's disease and other proteinopathies by combination therapy
CA2992386A1 (en) * 2015-07-16 2017-01-19 Probiodrug Ag Humanized antibodies
CN111518206B (zh) * 2019-02-01 2022-03-29 长春金赛药业有限责任公司 人源化抗Aβ单克隆抗体及其应用
EP4118111A1 (en) * 2020-03-10 2023-01-18 LifeArc Cyclic peptides

Similar Documents

Publication Publication Date Title
JP2022513331A5 (https=)
JP2020519643A5 (https=)
JP2017113019A5 (https=)
EA201000809A1 (ru) АНТИТЕЛА, СПЕЦИФИЧЕСКИЕ В ОТНОШЕНИИ ПРОТОФИБРИЛЛЯРНОЙ ФОРМЫ БЕЛКА β-АМИЛОИДА
JP2023540732A5 (https=)
JP2019535763A5 (https=)
JP2006519762A5 (https=)
JP2017500018A5 (https=)
JP2011528901A5 (https=)
EA200702095A1 (ru) Антитела, направленные против бета-амилоидного пептида, и способы их использования
JP2008538564A5 (https=)
JP2010521147A5 (https=)
JP2014502955A5 (https=)
JP2011528561A5 (https=)
JP2010502207A5 (https=)
RU2571204C3 (ru) Специфические связывающие агенты против в7-н1
PE20071055A1 (es) Anticuerpos anti mn
NO20083793L (no) Antistoffer mot amyloid-beta peptid
RU2018112861A (ru) Стабильные антитела, связывающиеся с несколькими антигенами
JP2010526028A5 (https=)
JP2021520393A5 (https=)
JP2010506596A5 (https=)
JP2016502515A5 (https=)
JP2006506942A5 (https=)
JP2025032102A5 (https=)